🇺🇸 FDA
Pipeline program

Indigo naturalis ointment

DMR101-IRB1-261

Phase 2 small_molecule completed

Quick answer

Indigo naturalis ointment for Psoriasis is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Psoriasis
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials